PKPD model Cyclophosphamide
Indication: Primary brain tumors in infants and young children
Interactive cyclophosphamide population PK simulator for pediatric primary brain tumors. Models parent drug plus 4-hydroxycyclophosphamide and CEPM metabolites after IV infusion, with age, phenobarbital, and CYP2B6 effects on exposure for this DNA-alkylating prodrug.
Drug Overview
Clinical Context
- Molecular Target
- DNA alkylation via phosphoramide mustard (cyclophosphamide prodrug)
- Drug Class
- Alkylating agent
- Therapeutic Area
- Pediatric neuro-oncology
- Indication
- Primary brain tumors in infants and young children
- Route of Administration
- Intravenous infusion
Model Information
- Model Type
- Population PK (2-compartment parent + linked 1-compartment metabolites)
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for PKPD model Cyclophosphamide allows you to explore concentration-time profiles under different dosing scenarios. The underlying Population PK (2-compartment parent + linked 1-compartment metabolites) model characterizes the pharmacokinetics of this alkylating agent following intravenous infusion administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the PKPD model Cyclophosphamide PK simulator?
This is a free, interactive pharmacokinetic simulator for PKPD model Cyclophosphamide used in Primary brain tumors in infants and young children. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does PKPD model Cyclophosphamide belong to?
PKPD model Cyclophosphamide is classified as a Alkylating agent that targets DNA alkylation via phosphoramide mustard (cyclophosphamide prodrug). It is used in the Pediatric neuro-oncology therapeutic area.
What route of administration does this model simulate?
This simulator models Intravenous infusion administration of PKPD model Cyclophosphamide. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a Population PK (2-compartment parent + linked 1-compartment metabolites) model. This model characterizes the time-course of drug concentrations following dosing.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Related Simulators
Ready to Simulate?
Launch the PKPD model Cyclophosphamide simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community